Reckitt Benckiser Group (RBGLY) Stock Forecast & Price Target

Reckitt Benckiser Group
Bull Case

Here are some ways that investors could benefit from investing in Reckitt Benckiser Group plc:

• Reckitt Benckiser Group plc is currently trading at $14.88, a price that reflects a significant discount to its 52-week high of $17.80, offering potential value for investors who believe the recent market overreaction to litigation risks is excessive.
• The company demonstrated strong operational resilience in the second quarter of 2026 by beating sales estimates with a 4.7% increase in like-for-like net revenue, driven by robust demand in emerging markets such as China and India which offset weakness in Europe.
• Management has signaled a commitment to returning capital to shareholders by launching a new £500 million share buyback program in July 2026, a move that supports the stock price and indicates confidence in the company's future cash flow generation.
• Analysts at UBS recently highlighted that an early rise in flu incidence could lift 2027 earnings forecasts for the company, suggesting that its portfolio of health and hygiene products is well-positioned to benefit from seasonal demand spikes.
• The company has achieved 12 consecutive quarters of double-digit sales growth in China by adapting its sales tactics to social-media shoppers, indicating a successful strategic pivot that is driving sustained revenue expansion in a key market.